These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14726677)

  • 1. Leukemic transformation.
    Lin YW; Aplan PD
    Cancer Biol Ther; 2004 Jan; 3(1):13-20. PubMed ID: 14726677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of human leukemias: new insights into therapy.
    Gilliland DG
    Semin Hematol; 2002 Oct; 39(4 Suppl 3):6-11. PubMed ID: 12447846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct mechanisms lead to HPRT gene mutations in leukemic cells.
    Lin YW; Perkins JJ; Zhang Z; Aplan PD
    Genes Chromosomes Cancer; 2004 Apr; 39(4):311-23. PubMed ID: 14978792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic alterations that drive leukemic stem cell self-renewal.
    van den Boom V; Horton SJ; Schuringa JJ
    J Stem Cells; 2012; 7(3):155-79. PubMed ID: 23619382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-ras mutation and karyotypic evolution are closely associated with leukemic transformation in myelodysplastic syndrome.
    Horiike S; Misawa S; Nakai H; Kaneko H; Yokota S; Taniwaki M; Yamane Y; Inazawa J; Abe T; Kashima K
    Leukemia; 1994 Aug; 8(8):1331-6. PubMed ID: 8057669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations.
    Drexler HG; Quentmeier H; MacLeod RA
    Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant isochromosome 17q and trisomy 14 in a patient with myelodysplastic syndrome in leukemic transformation.
    Park TS; Song J; Lee JH; Kim JS; Yang WI; Choi JR
    Ann Clin Lab Sci; 2009; 39(2):176-81. PubMed ID: 19429805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting DOT1L action and interactions in leukemia: the role of DOT1L in transformation and development.
    Barry ER; Corry GN; Rasmussen TP
    Expert Opin Ther Targets; 2010 Apr; 14(4):405-18. PubMed ID: 20230194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectral karyotyping study of chromosome abnormalities in human leukemia.
    Zhao L; Hayes K; Khan Z; Glassman A
    Cancer Genet Cytogenet; 2001 Jun; 127(2):143-7. PubMed ID: 11425454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activated leukemic oncogenes responsible for neoplastic transformation of hematopoietic cells].
    Baskaran D; Spirin PV; Prasolov VS
    Mol Biol (Mosk); 2010; 44(3):418-30. PubMed ID: 20608165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor.
    Hirose K; Abramovich C; Argiropoulos B; Humphries RK
    Oncogene; 2008 Oct; 27(46):6056-67. PubMed ID: 18604245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview: from discovery of candidate mutations to disease modeling and transformation mechanisms of acute leukemia.
    So CW
    Methods Mol Biol; 2009; 538():1-5. PubMed ID: 19277592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation.
    Nagase R; Inoue D; Pastore A; Fujino T; Hou HA; Yamasaki N; Goyama S; Saika M; Kanai A; Sera Y; Horikawa S; Ota Y; Asada S; Hayashi Y; Kawabata KC; Takeda R; Tien HF; Honda H; Abdel-Wahab O; Kitamura T
    J Exp Med; 2018 Jun; 215(6):1729-1747. PubMed ID: 29643185
    [No Abstract]   [Full Text] [Related]  

  • 15. Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
    Kunimoto H; Nakajima H
    Int J Hematol; 2017 Jul; 106(1):34-44. PubMed ID: 28555413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells.
    Pereira DS; Dorrell C; Ito CY; Gan OI; Murdoch B; Rao VN; Zou JP; Reddy ES; Dick JE
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8239-44. PubMed ID: 9653171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The molecular basis of leukemogenesis caused by MLL gene rearrangements].
    Yokoyama A
    Rinsho Ketsueki; 2015 Oct; 56(10):1942-9. PubMed ID: 26458432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant dendritic cell differentiation initiated by the Mll-Een fusion gene does not require leukemic transformation.
    Sun Q; Kong CT; Huang FP; Chan LC
    J Leukoc Biol; 2008 Jan; 83(1):173-80. PubMed ID: 17895399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of human leukemia.
    Gilliland DG
    Leukemia; 1998 Sep; 12 Suppl 1():S7-12. PubMed ID: 9777887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.
    Wuchter C; Harbott J; Schoch C; Schnittger S; Borkhardt A; Karawajew L; Ratei R; Ruppert V; Haferlach T; Creutzig U; Dörken B; Ludwig WD
    Leukemia; 2000 Jul; 14(7):1232-8. PubMed ID: 10914547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.